Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Clinical and Vaccine Immunology : CVI|September 26, 2008
Potentially exposed but uninfected individuals produce cytotoxic and polyfunctional human immunodeficiency virus type 1-specific CD8(+) T-cell responses which can be defined to the epitope levelA L Erickson, C B Willberg, V McMahan, et al.
Clinical and Diagnostic Laboratory Immunology|November 1, 1996
Comparison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assayR M Grant, E M Piwowar, E Katongole-Mbidde, et al.
HIV Medicine|March 4, 2014
Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventionsJ L Marcus, T Buisker, T Horvath, et al.
AIDS (London, England)|July 14, 2000
A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDSJ D Baxter, D L Mayers, D N Wentworth, et al.
Anticancer Research|July 1, 1983
Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum)D H Jones, N M Bleehen, R M Grant, et al.
The British Journal of Radiology|November 1, 1983
The penetration of misonidazole and desmethylmisonidazole into brain tumours and other central nervous system tissues in manN M Bleehen, R M Grant, D H Jones, et al.
AIDS (London, England)|June 27, 2001
Cerebrospinal fluid response to structured treatment interruption after virological failureR W Price, E E Paxinos, R M Grant, et al.
The Journal of Infectious Diseases|May 6, 1999
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcomeS G Deeks, N S Hellmann, R M Grant, et al.
AIDS (London, England)|January 12, 2001
Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patientsN T Parkin, S G Deeks, M T Wrin, et al.
The Journal of Clinical Investigation|June 17, 1998
High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infectionJ M McCune, R Loftus, D K Schmidt, et al.
Pageof 12